Toll free 1-855-572-3436 · Local 416-642-6472 · Email · Fax 416.538.4874

About UsReport Card ArchivesNews ArchivesStatisticsRegistrationTell Your StorySponsors/PartnersSponsorship GuidelinesCACC LinksPatient InfoDisclaimer

Facebook Find us on Facebook
Twitter Follow us on Twitter

CCAN Code of conduct
Q&A on the Code of Conduct

Sponsorship Guidelines

We are Canada's only registered, full-time, not-for-profit and non-charitable cancer group dedicated to evaluation of, and advocacy around, cancer system performance including patient/survivor family issues. Unlike charities that are required to restrict their advocacy to protect the charitable status, we have chosen to retain the freedom to engage in direct political lobbying on any cancer issue. The absence of charitable status allows freedom of expression but does limit fundraising that in turn affects our breadth of communication.

The full-time advocacy efforts of the CACC are therefore supported by individuals, volunteer members and private sector donors, including pharmaceutical sector and other corporate sponsors. Supporting the vision, mission, and values of CACC, and service to our constituents, is at the core of these endeavours.

Individual and private sector donors enable the CACC to maintain our "citizen watchdog" role in Canada's cancer control efforts. Additionally, in many cases, the goals of the Cancer Advocacy Coalition of Canada are better accomplished through collaboration and alliances with other organizations. Such partnerships will leverage the CACC's resources to help develop, produce and implement CACC mission-related programs, materials, and activities and increase the overall capacity of the CACC to fulfil its mission.

CACC will maintain public trust and confidence by careful consideration of the risks and benefits of all funding relationships. To assure accountability and transparency of all funding arrangements, CACC will be pleased to disclose publicly any responsibilities to any donors or partners.

Each potential strategic alliance is subjected to a cost-benefit test to ensure the advantages -- such as enhanced visibility, greater resources for programs, research and policy advocacy -- outweigh the costs of establishing the arrangement.

To discharge its educational and advocacy role, CACC must from time to time identify products, techniques, organizations and investigative or treatment methods that need to be brought to the attention of the CACC target audience. However, CACC will not engage in endorsement, advertising or promotion of any particular commercial organization, drug or product.

Collaborative relationships must:

  • Provide a demonstrable benefit to people with cancer
  • Demonstrate accountability and transparency about the way in which collaborative efforts will be undertaken Have clearly identified goals and objectives that are compatible with CACC's mission
  • Assure that CACC maintains final control over all editorial content, design and dissemination of information or educational products and services
  • Bring a strong commitment to the success of the alliance through agreement on the terms and conditions and demonstrable support from each partner's key leaders.
These guidelines are developed and unanimously supported by the board of directors of the CACC.

· Contact Us ·